MedPath

Effectiveness of Osteopathic Manipulative Treatment in Pediatric Asthma

Not Applicable
Conditions
Asthma
Registration Number
NCT01853189
Lead Sponsor
European Institute for Evidence Based Osteopathic Medicine
Brief Summary

Asthma is a highly prevalent chronic disease in children. Complementary and Alternative Medicine research on asthma showed a potential effect on pediatric patients.

Studies looking at the effect of Osteopathic Manipulative Treatment seems to reveal positive results.

The aim of study is to further explore the role of OMT on asthma in a pediatric population.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • children with asthma age between 5 and 14
Exclusion Criteria
  • associated co-morbities surgical patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Difference in Forced expiratory volume in the 1st second (FEV1) before and after OMTParticipants will be assessed at entry, after 3 and 6 months.
Secondary Outcome Measures
NameTimeMethod
Difference in fractional exhaled nitric oxide (FeNO) before and after OMTParticipants will be assessed at entry, after 3 and 6 months.
Difference in percentage of hemoglobin saturation before and after OMTParticipants will be assessed at entry, after 3 and 6 months.
Difference in Pediatric Asthma Quality of Life Questionnaire (PAQOL) before and after OMTParticipants will be assessed at entry, after 3 and 6 months.
Differences in the number, type and quality of somatic dysfunctionsParticipants will be assessed at entry, after 3 and 6 months
Difference in peak expiratory flow (PEF) before and after OMTParticipants will be assessed at entry, after 3 and 6 months.

Trial Locations

Locations (1)

Santo Spirito Hospital

🇮🇹

Pescara, Abruzzo, Italy

Santo Spirito Hospital
🇮🇹Pescara, Abruzzo, Italy
Francesco Cerritelli, MS,DO
Contact
+393394332801
francesco.cerritelli@ebom.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.